Effect of Repaglinide on Postprandial Lipemia in Type 2 Diabetes
Status:
Completed
Trial end date:
2003-03-13
Target enrollment:
Participant gender:
Summary
This trial is conducted in the United States of America (USA). The aim of this trial is to
compare the effect of repaglinide on postprandial lipemia in subjects with type 2 diabetes.